Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top HMG-CoA reductase inhibitors based on U.S. prescriptions in 2013
(in millions)
Top U.S. cholesterol-lowering drugs based on prescriptions 2013
This statistic displays the top ten HMG-CoA reductase inhibitors based on total number of U.S. prescriptions in 2013. In that year, Crestor was among the leading HMG-CoA reductase inhibitors with a total of 21.3 million precriptions in the United States. HMG-CoA reductase inhibitors or statins help lower cholesterol levels and is central in cholesterol production within the liver. It is used to prevent heart disease and decrease mortality within those with pre-existing cardiovascular disease.
Top HMG-CoA reductase inhibitors based on U.S. prescriptions in 2013
(in millions)
Prescriptions in millions
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2014

Region

United States

Survey time period

2013

Supplementary notes

HMG-CoA reductase: 3-hydroxy-3-methyl-glutaryl-CoA reductase. A class of drugs responsible for lowering cholesterol (statins).

Open this statistic in...
Top U.S. cholesterol-lowering drugs based on prescriptions 2013
This statistic displays the top ten HMG-CoA reductase inhibitors based on total number of U.S. prescriptions in 2013. In that year, Crestor was among the leading HMG-CoA reductase inhibitors with a total of 21.3 million precriptions in the United States. HMG-CoA reductase inhibitors or statins help lower cholesterol levels and is central in cholesterol production within the liver. It is used to prevent heart disease and decrease mortality within those with pre-existing cardiovascular disease.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.